During the WWDC keynote today, Apple announced macOS Golden Gate 27, the next major OS version for the Mac. Here are the details. During today’s WWDC keynote, Apple announced macOS Golden Gate 27.

ST’s STDRIVE102 gate-driver ICs for three-phase brushless motors have been augmented by the STDRIVE102P and STDRIVE102BP that feature an SPI interface to simplify configuring the gate current and ...

FRAMINGHAM, Mass. - The Massachusetts Port Authority, which owns and operates Boston Logan International Airport, unveiled the country’s first remote TSA checkpoint site, with ticket reservations now ...

Flying from Boston Logan International Airport soon? You could go through TSA security before arriving at the airport — once there, you can head straight to your gate. Starting June 1, the ...

STMicroelectronics has expanded its portfolio of motor-control components with the launch of two new gate-driver integrated circuits (ICs), designed to improve efficiency and simplify configuration in ...

The century-old garage, once the world’s largest parking structure, spans a full block where Bay Village meets Back Bay Two summers ago, the city of Boston and Los Angeles real estate firm CIM Group ...

Less than two months after smashing its own (unofficial) record in power density with its proprietary axial flux motor, YASA has unveiled a real-world application of the technology as an in-wheel ...

Add Futurism (opens in a new tab) More information Adding us as a Preferred Source in Google by using this link indicates that you would like to see more of our content in Google News results.

Most of Scout Motors’ reservation holders opted for the range extender option. That’s over 100,000 people who would still prefer a gasoline engine. In Scout’s upcoming vehicles, the combustion engine ...

The world of electric motor tech moves fast. Just months after YASA claimed an unofficial record for the most power-dense unit ever, the Mercedes-owned company specializing in axial-flux design motors ...

The aim of immunotherapy strategies is to leverage cells in the patient's own immune system to destroy tumor cells. Using a preclinical model, scientists from the Institut Pasteur and Inserm ...